| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4dfab3164e26299b50d6f446f5ff180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6ccf8d3ac8b58dfb6da1f95386fc285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09a5291bfc6ec4fa4fc7b4cdcdcdc57d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_873fae6ce6635cefb7cda7f3646085b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0035 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-86 |
| filingDate |
2006-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_017333aad6285272035c2c8192f5bb64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72faed24d0aab4108e9b3c2da46001ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5729d2f9d656ff83edd2946e97f296fc |
| publicationDate |
2007-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007075521-A2 |
| titleOfInvention |
Drug eluting stent for the treatment of dialysis graft stenoses |
| abstract |
A drug-eluting stent having a first cell pattern at one end and a second cell pattern on an opposite end. The cells in the first cell pattern have a smaller MCUSA than those in the second cell pattern. An anti-restonic drug can be coated on the first cell pattern and an anti-thrombotic drug on the second, with the anti-thrombotic drug overlaying and covering both the first and second cell patterns. The stent is operatively positionable at a distal graft-vein anastomosis with the first cell pattern adjacent the stenosis, and with the second cell pattern positioned adjacent the vein or the graft. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008097905-A1 |
| priorityDate |
2005-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |